BeOne Medicines
Zhiwei Wang joined BeiGene in April 2011 and is Senior Vice President, Research Head of Chemistry. Prior to joining BeiGene, he was Associate Director of Medicinal Chemistry at BioDuro. Dr. Wang previously worked at Novartis in San Diego as a Research Scientist in the Medicinal Chemistry Department. He also worked as Senior Scientist at Ionis Pharmaceuticals in San Diego.
Dr. Wang obtained his Ph.D degree in organic chemistry from Lanzhou University, and completed his postdoctoral training at Vanderbilt University. He is the author or co-author, and inventor or co-inventor, of more than 50 publications and patents.
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.